Cite
HARVARD Citation
Whittle, S. et al. (2020). Is high‐risk neuroblastoma induction chemotherapy possible without G‐CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatric blood & cancer. 67 (10), p. n/a. [Online].